Evolving an ‘India First’ policy
The countdown to the USTR for 2017 Special 301 Review has begun
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Editor’s note
Beyond the budget
The hype around the Union Budget 2017-18, especially after Prime Minister Modi's December 31 address was high but the general…
Pharma PSUs: Missed opportunity?
The turnover of the Indian pharmaceutical industry was estimated at Rs 2,04,627.1 crores in FY2015-16, registering a growth of 29…
Giving with a purpose
‘He who has health, has hope; and he who has hope, has everything,’ said Thomas Carlyle, social commentator and philosopher
More pain before the gain
An ICRA quarter update on the pharmaceutical sector does not have very encouraging news for 2017
Girding up for a VUCA world
The term VUCA, an acronym for volatility, uncertainty, complexity and ambiguity, was reportedly first coined by the US Army War…
More power to GST
The ongoing winter session of Parliament is crucial as there are many big ticket bills awaiting a nod
India Pharma Inc’s Trump card
Donald J Trump has beaten all odds to win the US election, much like the Indian pharmaceutical industry’s hard won rise as the…
In search of sustainable growth
When Ministers speak like CEOs, industry sits up and listens. The relatively newly minted state of Telangana is racing to catch up…
Abiding by the rules
The debate about replacing PET packaging with glass as packaging material for pharmaceuticals is reaching yet another milestone as…
Opportunities amidst challenges
MSF’s seven-year-old appeal campaign to reduce flu vaccine prices has finally borne fruit
Reviving APIs
Even as Indian pharmaceutical companies pursue aggressive plans for global expansion, there are deep challenges in the domestic…
Thriving through change
A recently released analysis of the global courier industry from
2010-2021, shows that the pharmaceutical sector accounts for just…
Testing the new FDI norms
The Modi government’s reforms have tinkered with FDI norms twice, first in November 2015 and more recently in June this year
Turning threat into opportunity
It is human nature to perceive change as a threat. But turning this threat into an opportunity is a crucial skill
Back to the basics
After taking a beating from overseas regulators for the past few years, analysts are finally sounding marginally cautious about…
Redrawing the Lakshman rekha
A national IPR policy, new FDI norms, a possible revamp of the Drugs & Cosmetics Act, Brexit: the pharma sector in India has a…
Betting big on M&As
Dr Reddy's Laboratories' June 11 announcement that it had entered into an agreement with Teva and Allergan to buy eight…
Moving up the green ladder
As the Modi Government launches its second anniversary celebration on May 26, the BJP will be organising 200 odd events over a…
Embracing quality as an opportunity
Concerned with declining pharma exports in the recent past, the Ministry of Commerce & Industry has tried to burnish the brand…